The binding of
p120-catenin and β-
catenin to the cytoplasmic domain of
E-cadherin establishes epithelial cell-cell adhesion. Reduction and loss of
catenin expression degrades
E-cadherin-mediated
carcinoma cell-cell adhesion and causes
carcinomas to progress into aggressive states. Since both
catenins are differentially regulated and play distinct roles when they dissociate from
E-cadherin, evaluation of their expression, subcellular localization and the correlation with
E-cadherin expression are important subjects. However, the same analyses are not readily performed on
squamous cell carcinomas in which
E-cadherin expression determines the
disease progression. In the present study, we examined expression and subcellular localization of
p120-catenin and β-
catenin in oral
carcinomas (n = 67) and its implications in the
carcinoma progression and
E-cadherin expression using immunohitochemistry. At the invasive front,
catenin-membrane-positive
carcinoma cells were decreased in the dedifferentiated (p120-
catenin, P < 0.05; β-
catenin, P < 0.05) and invasive
carcinomas (p120-
catenin, P < 0.01; β-
catenin, P < 0.05) and with the
E-cadherin staining (p120-
catenin, P < 0.01; β-
catenin, P < 0.01).
Carcinoma cells with β-
catenin cytoplasmic and/or nuclear staining were increased at the invasive front compared to the center of
tumors (P < 0.01). Although the
p120-catenin isoform shift from three to one associates with
carcinoma progression, it was not observed after TGF-β,
EGF or TNF-α treatments. The total amount of
p120-catenin expression was decreased upon co-treatment of TGF-β with
EGF or TNF-α. The above data indicate that
catenin membrane staining is a primary determinant for
E-cadherin-mediated cell-cell adhesion and progression of oral
carcinomas. Furthermore, it suggests that loss of
p120-catenin expression and cytoplasmic localization of β-
catenin fine-tune the
carcinoma progression.